Cargando…
Reducing Amyloid Plaque Burden via Ex Vivo Gene Delivery of an Aβ-Degrading Protease: A Novel Therapeutic Approach to Alzheimer Disease
BACKGROUND: Understanding the mechanisms of amyloid-β protein (Aβ) production and clearance in the brain has been essential to elucidating the etiology of Alzheimer disease (AD). Chronically decreasing brain Aβ levels is an emerging therapeutic approach for AD, but no such disease-modifying agents h...
Autores principales: | Hemming, Matthew L, Patterson, Michaela, Reske-Nielsen, Casper, Lin, Ling, Isacson, Ole, Selkoe, Dennis J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1952204/ https://www.ncbi.nlm.nih.gov/pubmed/17760499 http://dx.doi.org/10.1371/journal.pmed.0040262 |
Ejemplares similares
-
The amyloid hypothesis of Alzheimer's disease at 25 years
por: Selkoe, Dennis J, et al.
Publicado: (2016) -
If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline?
por: Haass, Christian, et al.
Publicado: (2022) -
Neuroinflammation mediated by IL-1β increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease
por: Koprich, James B, et al.
Publicado: (2008) -
Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-β plaques
por: Hashimoto, Tadafumi, et al.
Publicado: (2020) -
β-Amyloid Degradation and Alzheimer's Disease
por: Wang, Deng-Shun, et al.
Publicado: (2006)